4
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4534 |
BMS-309403
|
FABP | Metabolism |
BMS309403 是有效的、选择性脂肪细胞脂肪酸结合蛋白 aFABP 抑制剂。它可改善载脂蛋白 E 缺乏症小鼠和培养的人内皮细胞的内皮功能。它能够与蛋白质内部的脂肪酸结合口袋相互作用,竞争性地抑制内源性脂肪酸的结合。 | |||
T15506 | HTS01037 | Others | Others |
HTS01037 is an inhibitor of fatty acid-binding. HTS01037 is a competitive antagonist of protein-protein interactions mediated by AFABP/aP2 (Ki: 0.67 μM). | |||
T37614 |
LDN-0088050
|
||
LDN 0088050 is selectivity adipocyte fatty acid binding protein (AFABP, FABP4) inhibitor with Ki values of 0.29 and 1.3 μM for FABP4 and FABP3, respectively. LDN 0088050 binds to FABP4 with a Kd of 2.05 μM[1]. Ki: 0.29 μM (FABP4), 1.3 μM (FABP3)[1]Kd: 2.05 μM (FABP4)[1] LDN 0088050 significantly inhibits LPS-induced expression of both TNFα and IL-6 in RAW264.7 cells[1]. [1]. Zhou Y, et al. The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biolo... | |||
T63355 |
BMS-309403 sodium
|
||
BMS-309403 sodium 是一种有效的选择性脂肪细胞脂肪酸结合蛋白aFABP, 也称为FABP4,aP2抑制剂,对 FABP4,FABP3 和 FABP5 的Ki 分别为 <2 nM,250 nM,350 nM。BMS-309403 sodium 与蛋白质内部的脂肪酸结合口袋相互作用,竞争性地抑制内源性脂肪酸的结合。BMS-309403 sodium 可改善载脂蛋白E 缺乏症小鼠和培养的人内皮细胞的内皮功能。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02103 |
FABP4 Protein, Human, Recombinant (29 Ala/Thr, His)
HEL-S-104,fatty acid binding protein 4, adipocyte,A-FABP, |
Human | E. coli |
FABP4 Protein, Human, Recombinant (29 Ala/Thr, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 16 kDa and the accession number is P15090. |